The pharmacology of GLP-1, GIP, and glucagon based therapies has been the subject of decades of research
Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G et al (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
I spend half my time trying to differentiate between some of the sketchy stuff that is going on online. About 42% of online pharmacies selling semaglutide are operating illegally, according to a study published this month in the medical journal JAMA Network Open
However, 2025 has marked a pivotal turning point, characterized by a significant weight loss drug price drop 2025
Several GLP-1 receptor agonists are available, with varying pharmacokinetic profiles and approved indications